|
LSM5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
5.20349985322355E-10 |
| Normal-vs-Stage3 |
1.6269208202857E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.086100E-02 |
| Stage1-vs-Stage3 |
4.398800E-01 |
| Stage1-vs-Stage4 |
5.069700E-02 |
| Stage2-vs-Stage3 |
2.190200E-01 |
| Stage2-vs-Stage4 |
4.156900E-03 |
| Stage3-vs-Stage4 |
1.690030E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.84979999984236E-07 |
| Normal-vs-Asian |
5.83977310952832E-14 |
| Caucasian-vs-AfricanAmerican |
6.455600E-01 |
| Caucasian-vs-Asian |
6.511400E-01 |
| AfricanAmerican-vs-Asian |
8.281600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.62536650805123E-12 |
| Male-vs-Female |
3.233400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(81-100Yrs) |
4.43450000000567E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.307790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.395430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.336000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.307600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.461420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.364200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.775400E-01 |
| Classical-VS-Follicular |
5.414400E-01 |
| Classical-VS-Other |
2.385800E-01 |
| Classical-VS-Normal |
4.32986979603811E-15 |
| Tall-VS-Follicular |
1.916820E-01 |
| Tall-VS-Other |
4.320600E-01 |
| Tall-VS-Normal |
1.13242748511766E-14 |
| Follicular-VS-Other |
2.597400E-01 |
| Follicular-VS-Normal |
1.63835611743934E-12 |
| Other-VS-Normal |
1.74014999999583E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
7.647700E-02 |
|
|
